Literature DB >> 6973434

Immunological evaluation of asymptomatic carriers of hepatitis B virus.

Y Levo, D Shouval, R Tur-Kaspa, S Wollner, S Penchas, A Zlotnick, M Eliakim.   

Abstract

The immune system of 69 asymptomatic HBsAg carriers with normal liver function tests was evaluated. B cell function, as documented by serum immunoglobulin levels, number of mouse rosette-forming lymphocytes and lymphocyte reactivity to staphylococcal protein A, was intact. On the other hand, T cell function was markedly impaired. This was manifested by a significant decrease in E rosette-forming lymphocytes, an increase in stable rosette-forming cells and decreased reactivity to phytohaemagglutinin and concanavalin A. These data rule out the possibility that the immunological aberrations associated with hepatitis B infection are secondary to liver injury. The abnormal immune state either precedes the viral infection, thus predisposing to the acquisition of a carrier state or, alternatively, is a direct result of the infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973434      PMCID: PMC1537213     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Lymphocyte subpopulations in chronic active hepatitis: increase in lymphocytes forming stable E-rosettes.

Authors:  U Galili; M Eliakim; S Slavin; M Schlesinger
Journal:  Clin Immunol Immunopathol       Date:  1975-11

2.  Letter: T cells and B cells in HBsAg-positive patients with chronic persistent hepatitis and asymptomatic carriers.

Authors:  H Ishimaru; K Ito; J Nakagawa
Journal:  Ann Intern Med       Date:  1976-04       Impact factor: 25.391

3.  T and B lymphocytes in patients with chronic active hepatitis (CAH).

Authors:  M Colombo; S J Vernace; F Paronetto
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

4.  Lymphocyte subpopulations in chronic liver disease.

Authors:  I G McFarlane; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

5.  Immunological surveillance against altered self components by sensitised T lymphocytes in lymphocytic choriomeningitis.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

6.  Cell-mediated immune response to hepatitis B antigen in patients with liver disease.

Authors:  M J Gerber; A Phuangsab; S B Vittal; D Dourdourekas; F Steigmann; B F Clowdus
Journal:  Am J Dig Dis       Date:  1974-07

7.  Predicting progression of acute type-B hepatitis to chronicity.

Authors:  S Sherlock
Journal:  Lancet       Date:  1976-08-14       Impact factor: 79.321

Review 8.  Structure and nature of hepatitis B antigen.

Authors:  C R Howard; C J Burrell
Journal:  Prog Med Virol       Date:  1976

9.  Peripheral blood lymphocyte populations in chronic liver disease.

Authors:  H C Thomas; M Freni; J Sanchez-Tapias; D de Villiers; S Jain; S Sherlock
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

10.  H-2 restriction of virus-specific cytotoxicity across the H-2 barrier. Separate effector T-cell specificities are associated with self-H-2 and with the tolerated allogeneic H-2 in chimeras.

Authors:  R M Zinkernagel
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  5 in total

1.  Detection of cellular and humoral immunity to hepatitis B surface antigen (HBsAg) in asymptomatic HBsAg carriers.

Authors:  S P Sylvan; U B Hellström; P R Lundbergh
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

2.  Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.

Authors:  G M Dusheiko; J H Hoofnagle; W G Cooksley; S P James; E A Jones
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

3.  Cryoglobulinemia in acute type-A hepatitis.

Authors:  M Shalit; S Wollner; Y Levo
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

Review 4.  Primary hepatocellular carcinoma. Present state of the disease and prospects for the future.

Authors:  C J Oon; M A Friedman
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  Low responsiveness of hepatitis B virus-transgenic mice in antibody response to T-cell-dependent antigen: defect in antigen-presenting activity of dendritic cells.

Authors:  S M Akbar; M Onji; K Inaba; K Yamamura; Y Ohta
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.